PMH34 Long-Term Cost-Effectiveness of Atypical Antipsychotics for Schizophrenia in the United States

Autor: Rajagopalan, K., O'Day, K., Meyer, K., Pikalov, A.A., iii, Loebel, A.
Zdroj: In Value in Health June 2012 15(4):A87-A87
Databáze: ScienceDirect